A new study found that fixing energy balance in the brain reversed symptoms of advanced Alzheimer’s in mice.  Researchers ...

Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's Work will inform Phase 2 trials assessing the potential of MNA-001 to ...

A nationwide clinical trial is testing whether an existing drug could benefit patients with Alzheimer's disease, in hopes of making symptom-improving medication more accessible for people experiencing ...

A team of investigators looked at possible dementia clinical trial requirements that could exclude people based on race and ethnicity. Overall, 82% of the trials they examined had criteria that ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...

Nearly one million people in the UK are estimated to have dementia, the UK’s biggest killer. Yet, dementia research progress is stalling as dementia clinical trials struggle to recruit. In 2023/24 ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly available cough syrup that's already being studied for its positive effect on ...

Despite the definitive failure of Novo Nordisk’s semaglutide in Alzheimer’s, biotech executives, analysts and other industry ...

DELRAY BEACH, Fla. — November is Alzheimer's Awareness Month, and if you have a loved one in the beginning stages of the disease, a local clinical trial could offer some hope. It's called the Benfo ...

"Menopause hormone therapy is widely used to manage menopausal symptoms, yet its impact on memory, cognition, and dementia ...

Routine vaccinations offered to adults may help protect against dementia, recent research has shown.

Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), ...